Scholars Central

Mini reviewPublished 24 Nov 2021

Amyloidosis-A Mini Review

Authors: Mishi Bhushan

Journal of Clinical Research & Bioethics

Volume 12 · Issue 6 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Amyloidosis is a heterogenous acquired or hereditary collection of disease entities that presents as a localized disease or multisystemic disorder due to the abnormal deposition of beta-sheet fibrillar protein aggregates in tissue. Classification depends on amyloid type and pathophysiology is multifactorial. Diagnosis by tissue biopsy, immunohistochemistry, genesequencing, mass spectrometry, and electron microscopy as well as demonstration of congo red staining with apple green birefringence under polarized light is characteristic. Imaging with echocardiogram, EKG, MRI and CT can illustrate the degree of organ damage. Treatment is variable and usually depends on the type of amyloidosis. We discuss the ethical dilemmas of diagnosis and treatment of amyloidosis.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Clinical Research & Bioethics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical Research & Bioethics
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Mishi Bhushan”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels